$QBTS

DiLullo John D sold $192K of QBTS

DiLullo John D sold 7,850 shares of D-Wave Quantum Inc. (QBTS) at $24.43 ($0.19M total) on 2026-06-05 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · DiLullo John D
Published Jun 8, 2026, 8:14 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 8, 2026, 8:16 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$QBTS
Neutral
high confidence
Mentioned
$QBTS
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$QBTSNeutralLow
01

Why it matters

The filing confirms the sale size, price, and that it was executed under a pre-arranged 10b5-1 plan, which generally limits interpretive impact on fundamentals.

02

Market read

Provides a fresh, primary-source datapoint on insider selling, but lacks new business or regulatory catalysts.

03

What to watch

Traders may over-weight insider sales; without accompanying buy/sell pattern context or new operational/regulatory news, the signal is usually weak.

Relevance 3/10Novelty 8/10Timing: filed 2026-06-08 (covers sale dated 2026-06-05)

Background

The article is an SEC Form 4 insider transaction filing (director selling shares) for D-Wave Quantum Inc.

Company-level read

Ticker impact

$QBTSNeutralHigh confidence
Context

Director John D DiLullo sold 7,850 shares of D-Wave Quantum on 2026-06-05 for ~$191.8K via an open-market sale under a 10b5-1 plan.

Expected impact

Low likelihood of sustained price impact; any reaction is likely muted and short-lived.

Evidence & confidence

The disclosure is a Form 4 insider transaction and explicitly states a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

Market effects

No direct sector read-through; this is company-specific insider liquidity disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect scheduled diversification rather than bearish expectations.

Key entities

  • D-Wave Quantum Inc.

    QBTS, the company whose director executed an open-market sale under a 10b5-1 plan.

  • John D DiLullo

    Director who sold 7,850 shares on 2026-06-05.

Related articles

$QBTSMed

D-Wave’s $550M Quantum Computing Bet Makes Error Correction 10X Cheaper

D-Wave says a Nature peer-reviewed paper shows its dual-rail erasure qubits can entangle with low error rates, enabling cheaper quantum error correction. It reports ~500 ns gate time, ~0.5% photon loss (erasure), ~0.1% phase errors, and ~1 in 1,000,000 bit-flips, with ~99.9% two-qubit fidelity. D-Wave also reported Q2 results: $3.1M quarterly revenue, $35.5M first-half bookings, $40.7M backlog, and a $48M net loss.

$QBTSMed

D-Wave Quantum Q2 Earnings Call Highlights

D-Wave Quantum reported a wider adjusted EBITDA loss of $37.1 million for Q2, citing higher personnel spending. GAAP gross profit fell 14% to $1.7 million, with gross margin down to 55.4%. First-half 2026 revenue was $5.9 million, down 67%, while bookings rose to $35.5 million and backlog reached $40.7 million. The company also discussed QCaaS production deployments and gate-model roadmap after its Quantum Circuits acquisition.

$QBTSMed

Why D-Wave Quantum Stock Just Fell

D-Wave Quantum Inc. shares (QBTS) fell about 9.3% after its Q2 report missed Wall Street expectations. Revenue was $3.1 million versus $4.1 million expected, and net loss was $0.13 per share versus $0.09 expected. Operating expenses rose 93% to $55 million, and adjusted EBITDA loss widened 85% to $37.1 million. Cash was $546.2 million.

$QBTSMed

D-Wave Quantum Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

D-Wave Quantum Inc. reported Q2 2026 sales of $3.08 million, down from $3.1 million a year earlier. Net loss was $48.03 million versus $167.33 million. Basic and diluted loss per share from continuing operations were $0.13 versus $0.55. For six months, sales fell to $5.93 million from $18.1 million, with net loss $66.39 million versus $172.75 million.